Botanical species · safety record

Cedrus libani

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Cedrus libani. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cedrus libani A.Rich.

5Constituent measurements

1Safety records

4Cited sources

13Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 13 licensed products naming Cedrus libani as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Jeunes pousses
Young shoots

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lignans	Wood	Solvent extraction	≥ 1.8 Milligram/gram	GC-MS	Resolve DOI
Lignans	Wood	Solvent extraction	≤ 11 Milligram/gram	GC-MS	Resolve DOI
Myrcene	Leaves	Solvent extraction	≤ 6.3 Percent	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Myrcene	Leaves	Solvent extraction	≥ 2.7 Percent	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Tannins	Leaves	Solvent extraction	19.3 Percent	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Cone	Essential oil (as part-nature)	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Willfor, S., Hafizoglu, H., Tumen, I., Yazici, H., Arfan, M., Ali, M., Holmbom, B. Extractives of Turkish and Pakistani tree species. HOLZ ALS ROH-UND WERKSTOFF, 2007, vol. 65, no. 3, p. 215-221. DOI
Loizzo, M. R., Saab, A. M., Statti, G. A., Menichini, F. Composition and alpha-amylase inhibitory effect of essential oils from Cedrus libani . Fitoterapia, 2007, vol. 78, no. 4, p. 323-326. DOI
Karabulut, A., Canbolat, O., Ozkan, C.O., Kamalak, A. Potential nutritive value of some mediterranean shrub and tree leaves as emergency food for sheep in winter. Livestock research for rural development, 2006, vol. 18, no. 6, p. 81.
Fleisher, A., Fleisher, Z. The volatiles of the leaves and wood of Lebanon Cedar (Cedrus libani A. Rich) aromatic plants of the Holy Land and the Sinai. Part XIV . Journal of essential oil research, 2000, vol. 12, no. 6, p. 763-765.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature